NewsDesk  @infectiousdiseasenews Pfizer Inc. and BioNTech SE today announced a new research, development and commercialization collaboration to develop a potential first mRNA-based vaccine for the prevention...

By NewsDesk  @bactiman63 GlaxoSmithKline announced that the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted unanimously to recommend...

NewsDesk  @infectiousdiseasenews The UK Health Security Agency announced that as of September 1, the Shingrix vaccine will be available for people who are 70 to 79 years of age with weakened immune systems...

NewsDesk @bactiman63 GlaxoSmithKline today announced that the US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes...

With the nation focused on the delivery of a COVID vaccine, the CDC wants to ensure that older individuals are protected against other prevalent yet preventable diseases that can lead to severe health...

Earlier this week, Senate Minority Leader, Chuck Schumer of New York made a statement concerning the shortage of the popular shingles vaccine, Shingrix and seemed to link it to the current government...

From the Infectious Diseases Society of America (IDSA): People newly diagnosed with cancer, particularly blood cancers, and those treated with chemotherapy have a greater risk of developing shingles, according...

A new and more effective herpes zoster (shingles) vaccine, Shingrix®, is now available in all Albertsons Companies pharmacies across the United States. Shingrix® was recently approved by the FDA and...

My guest on today’s podcast says that while there were many successes in human development in 2017, arguably, the most significant achievements of the last 12 months were in global health. Public...

First evidence of the shingles vaccine programme shows a substantial reduction in cases and long-term complications. A new study in the Lancet Journal of Public Health shows a substantial decrease in...